Literature DB >> 10378024

Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia.

S Saito1, H Umekage, Y Sakamoto, M Sakai, K Tanebe, Y Sasaki, H Morikawa.   

Abstract

PROBLEM: To examine whether preeclampsia involves type-1 T-helper (TH1) immune hyperactivity. METHOD OF STUDY: Expression of HLA-DR, a cell-surface marker of activation, was analyzed on CD3+, CD4+, and CD8+ T cells in 15 preeclamptic patients and 15 normal pregnant women using flow cytometry. Additionally, peripheral blood mononuclear cells from preeclamptic patients and normal pregnant women were cultured with or without phytohemagglutinin (PHA) stimulation, and interleukin (IL)-2, IL-4, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha concentrations were determined in the supernatant by immunoassays.
RESULTS: HLA-DR antigen was expressed more strongly on CD3+ T cells in preeclamptic patients than in normal subjects. In preeclampsia, HLA-DR was expressed more strongly in CD8+ T cells than in CD4- T cells. More TNF-alpha, IL-2, and IFN-gamma were produced by unstimulated and stimulated cultured peripheral blood mononuclear cells from preeclampsia patients than by those from normal subjects. TNF-alpha/IL-4, IL-2/IL-4, and IFN-gamma/IL-4 ratios were higher in preeclamptic patients than in the normal group. Significant positive correlations were observed between mean blood pressure and concentrations of the Th-1 type cytokines IL-2, IFN-gamma, and TNF-alpha.
CONCLUSION: Up-regulation of Th1 responses and down-regulation of Th2 responses occur in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378024     DOI: 10.1111/j.1600-0897.1999.tb00442.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  39 in total

1.  Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats.

Authors:  Denise C Cornelius; Javier Castillo; Justin Porter; Lorena M Amaral; Nathan Campbell; Adrienne Paige; Alexia J Thomas; Ashlyn Harmon; Mark W Cunningham; Kedra Wallace; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-26       Impact factor: 3.619

2.  Plasma granulysin concentrations and preeclampsia risk.

Authors:  Chunfang Qiu; Shigeru Saito; Masatoshi Sakai; Kazuyuki Ogawa; Kinya Nagata; Michelle A Williams
Journal:  Clin Biochem       Date:  2006-08-16       Impact factor: 3.281

3.  Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods.

Authors:  Daniel B DiGiulio; Mariateresa Gervasi; Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Kimberley S Seok; Ricardo Gómez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Enrique Oyarzún; Chong Jai Kim; David A Relman
Journal:  J Perinat Med       Date:  2010-09       Impact factor: 1.901

4.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

5.  Expression pattern of tumor necrosis factor alpha in placentae of idiopathic fetal growth restriction.

Authors:  Shaima M Almasry; Magda A Eldomiaty; Amr K Elfayomy; Fawzia A Habib
Journal:  J Mol Histol       Date:  2012-03-30       Impact factor: 2.611

6.  IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases.

Authors:  Prince A Barnie; Xin Lin; Yueqin Liu; Huaxi Xu; Zhaoliang Su
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia.

Authors:  Y Sasaki; D Darmochwal-Kolarz; D Suzuki; M Sakai; M Ito; T Shima; A Shiozaki; J Rolinski; S Saito
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

8.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12

9.  Adiponectin in severe preeclampsia.

Authors:  Jyh Kae Nien; Shali Mazaki-Tovi; Roberto Romero; Offer Erez; Juan Pedro Kusanovic; Francesca Gotsch; Beth L Pineles; Ricardo Gomez; Samuel Edwin; Moshe Mazor; Jimmy Espinoza; Bo Hyun Yoon; Sonia S Hassan
Journal:  J Perinat Med       Date:  2007       Impact factor: 1.901

10.  Myeloid and lymphoid dendritic cells in normal pregnancy and pre-eclampsia.

Authors:  D Darmochwal-Kolarz; J Rolinski; J Tabarkiewicz; B Leszczynska-Gorzelak; J Buczkowski; K Wojas; J Oleszczuk
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.